Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies

Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Sukumaran, A; Loyse, N; Bharwani, N; Rockall, A; Gabra, H; El-Bahrawy, M; Wasan, H; Leonard, RCF; Habib, NA; Gribben, JG; Ghazaly, EA; McGuigan, C

doi:https://www.dx.doi.org/10.1200/jco.2015.33.15_suppl.2514

File(s)

ProGeM1_final_res_ASCO2015.pdf (93.61 KB)

Published version

Author(s)

Blagden, SP

Rizzuto, I

Stavraka, C

O'Shea, D

Suppiah, P

more

Type

Conference Paper

Date Issued

2015-05-20

Date Acceptance

2015-05-01

Citation

Journal of Clinical Oncology, 2015, 33 (15)

URI

http://hdl.handle.net/10044/1/50783

DOI

https://www.dx.doi.org/10.1200/jco.2015.33.15_suppl.2514

ISSN

0732-183X

Publisher

American Society of Clinical Oncology

Journal / Book Title

Journal of Clinical Oncology

Volume

33

Issue

15

Copyright Statement

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000358036900547&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Source

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Subjects

Science & Technology

Life Sciences & Biomedicine

Oncology

Publication Status

Published

Start Date

2015-05-29

Finish Date

2015-06-02

Coverage Spatial

Chicago, IL